triclosan has been researched along with Bacterial Disease in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Controlling bacterial infections in plants is a major challenge owing to the appearance of resistant strains." | 5.91 | Resistance-driven innovations in the discovery of bactericides: novel triclosan derivatives decorating isopropanolamine moiety as promising anti-biofilm agents against destructive plant bacterial diseases. ( Feng, YM; Liu, LW; Liu, SS; Wang, PY; Xiao, WL; Yang, S; Zhang, H; Zhang, JJ; Zhang, JR; Zhou, X, 2023) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Controlling bacterial infections in plants is a major challenge owing to the appearance of resistant strains." | 1.91 | Resistance-driven innovations in the discovery of bactericides: novel triclosan derivatives decorating isopropanolamine moiety as promising anti-biofilm agents against destructive plant bacterial diseases. ( Feng, YM; Liu, LW; Liu, SS; Wang, PY; Xiao, WL; Yang, S; Zhang, H; Zhang, JJ; Zhang, JR; Zhou, X, 2023) |
| "The triclosan glycosides were also generally found to be more water soluble and much more selective than the underivatized triclosan, making them ideal both for the targeted inhibition of bacterial growth and as agents for the selective recovery of bacteria from mixed cultures." | 1.51 | Synthesis and antibacterial profiles of targeted triclosan derivatives. ( Bovill, RA; Howse, GL; Osborn, HMI; Stephens, PJ, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Howse, GL | 1 |
| Bovill, RA | 1 |
| Stephens, PJ | 1 |
| Osborn, HMI | 1 |
| Vieira, D | 1 |
| Angel, SN | 1 |
| Honjol, Y | 1 |
| Masse, M | 1 |
| Gruenheid, S | 1 |
| Harvey, EJ | 1 |
| Merle, G | 1 |
| Ardila, CM | 1 |
| Bedoya-García, JA | 1 |
| Zhang, JJ | 1 |
| Feng, YM | 1 |
| Zhang, JR | 1 |
| Xiao, WL | 1 |
| Liu, SS | 1 |
| Zhou, X | 1 |
| Zhang, H | 1 |
| Wang, PY | 1 |
| Liu, LW | 1 |
| Yang, S | 1 |
| Kuti, BP | 1 |
| Ogunlesi, TA | 1 |
| Oduwole, O | 1 |
| Oringanje, C | 1 |
| Udoh, EE | 1 |
| Meremikwu, MM | 1 |
| Bayston, R | 1 |
| Ashraf, W | 1 |
| Pelegrin, I | 1 |
| Fowkes, K | 1 |
| Bienemann, AS | 1 |
| Singleton, WGB | 1 |
| Scott, IS | 1 |
| Qu, H | 1 |
| Knabe, C | 1 |
| Radin, S | 1 |
| Garino, J | 1 |
| Ducheyne, P | 1 |
| Ortalda, C | 1 |
| Noli, C | 1 |
| Cena, T | 1 |
| Geraldo, IM | 1 |
| Gilman, A | 1 |
| Shintre, MS | 1 |
| Modak, SM | 1 |
| Gómez-Alonso, A | 1 |
| García-Criado, FJ | 1 |
| Parreño-Manchado, FC | 1 |
| García-Sánchez, JE | 1 |
| García-Sánchez, E | 1 |
| Parreño-Manchado, A | 1 |
| Zambrano-Cuadrado, Y | 1 |
| Aliaga, A | 1 |
| Castells, A | 1 |
| Kriznik, D | 1 |
| Lalosević, J | 1 |
| Marrón, J | 1 |
| Moragas, J | 1 |
| Ocaña, J | 1 |
| Schindléry, C | 1 |
| Faoagali, JL | 1 |
| George, N | 1 |
| Fong, J | 1 |
| Davy, J | 1 |
| Dowser, M | 1 |
| Levy, SB | 1 |
| Li, Q | 1 |
| Lee, JY | 1 |
| Castillo, R | 1 |
| Hixon, MS | 1 |
| Pujol, C | 1 |
| Doppalapudi, VR | 1 |
| Shepard, HM | 1 |
| Wahl, GM | 1 |
| Lobl, TJ | 1 |
| Chan, MF | 1 |
| Allegra, F | 1 |
| Cainelli, T | 1 |
| Csermely, E | 1 |
| Gelmetti, C | 1 |
| Gandola, M | 1 |
| Martina, G | 1 |
| Santini, R | 1 |
| Tomasini, C | 1 |
| Zanca, A | 1 |
| Bodey, GP | 1 |
| Ebersole, R | 1 |
| Hong, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Residual Effect of Chlorhexidine 2% / Isopropyl Alcohol 70% Compared to Triclosan 1% / Isopropyl Alcohol 70%[NCT01762904] | Phase 3 | 135 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"135 units of measurement to test two antiseptics and two controls. Principal unit of measurement: four determinations of bacterial counts in a subject for antiseptics and controls to test each of the application sites.~All volunteers was provided with a neutral soap without antiseptics for use of two weeks. 2% chlorhexidine in 70% isopropyl alcohol and 1% triclosan in 70% isopropyl alcohol, Deionized water redistilled and Scrub the skin without prior application of any substance was tested. We prepared four skin's areas of 25 cm2, two in each forearm. The solution remained on the skin for 60s, 3h and 24h.~Presence of allergy or any skin reaction at 24 hours after the antiseptic application." (NCT01762904)
Timeframe: 24 hours
| Intervention | participants (Median) |
|---|---|
| Whole Group of 135 Units of Measurement | 0 |
"135 units of measurement to test two controls. Principal unit of measurement: four determinations of bacterial counts in a subject for antiseptics and controls to test each of the application sites.~All volunteers was provided with a neutral soap without antiseptics for use of two weeks. Deionized water redistilled (Control 2: Control with scrub) and Scrub the skin without prior application of any substance (Control1: Control without scrub) was tested. Were prepared two skin's areas of 25 cm2 randomly selected. The solution remained on the skin for 60s, 3h and 24h.~Cultures was taken with a scrub-cup of 5 cm2 pressed over the skin, added a 3 mL of culture broth. The skin was scrub with a sterile rubber policeman for 1 minute and the procedure conducted once again. Both aliquots came together in a sterile tube, a sample of 50 microliters were spread in a plate containing a neutralizing agar and were incubated at 35°C for 24 h." (NCT01762904)
Timeframe: 24 hrs
| Intervention | (CFU/cm2) (Median) | |||||
|---|---|---|---|---|---|---|
| Control 1: without scrub 0 h | Control 2: scrub with Deionized water redisti 0 h | Control 1: without scrub 3 h | Control 2: scrub with Deionized water redisti 3 h | Control 1: without scrub 24 h | Control 2: scrub with Deionized water redisti 24 h | |
| Whole Group of 135 Units of Measurement | 480 | 216 | 288 | 96 | 288 | 96 |
"135 determinations to evaluate residual effect of 2% chlorhexidine in 70% isopropyl alcohol.~All volunteers was provided with a neutral soap without antiseptics for use of two weeks. 2% chlorhexidine in 70% isopropyl alcohol was tested. Were prepared the skin area of 25 cm2 randomly selected. The solution remained on the skin for 60s, 3h and 24h, everyone on different days.~Cultures was taken with a scrub-cup of 5 cm2 pressed over the skin, added a 3 mL of culture broth. The skin was scrub with a sterile rubber policeman for 1 minute and the procedure conducted once again. Both aliquots came together in a sterile tube, a sample of 50 microliters were spread in a plate containing a neutralizing agar and were incubated at 35°C for 24 h." (NCT01762904)
Timeframe: 24 hours
| Intervention | (CFU/cm2) (Median) | ||
|---|---|---|---|
| 0 h | 3 h | 24 h | |
| Whole Group of 135 Units of Measurement | 24 | 48 | 24 |
"135 determinations to test 1% triclosan in 70% isopropyl alcohol.~All volunteers was provided with a neutral soap without antiseptics for use of two weeks. 1% triclosan in 70% isopropyl alcohol was tested. Were prepared the skin area of 25 cm2 randomly selected. The solution remained on the skin for 60s, 3h and 24h, everyone on different days.~Cultures was taken with a scrub-cup of 5 cm2 pressed over the skin, added a 3 mL of culture broth. The skin was scrub with a sterile rubber policeman for 1 minute and the procedure conducted once again. Both aliquots came together in a sterile tube, a sample of 50 microliters were spread in a plate containing a neutralizing agar and were incubated at 35°C for 24 h." (NCT01762904)
Timeframe: 24 hours
| Intervention | (CFU/cm2) (Median) | ||
|---|---|---|---|
| 0 h | 3 h | 24 h | |
| Whole Group of 135 Units of Measurement | 48 | 48 | 96 |
3 reviews available for triclosan and Bacterial Disease
| Article | Year |
|---|---|
Bacterial resistance to antiseptics used in dentistry: A systematic scoping review of randomized clinical trials.
Topics: Anti-Infective Agents, Local; Bacterial Infections; Chlorhexidine; Dentistry; Humans; Randomized Con | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Hand hygiene for the prevention of infections in neonates.
Topics: Age Factors; Anti-Infective Agents, Local; Bacterial Infections; Bias; Chlorhexidine; Cross-Over Stu | 2021 |
4 trials available for triclosan and Bacterial Disease
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
An overview of two comparative multicentre trials with halometasone/triclosan cream in acute superficial bacterial skin infections.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Bacterial Infections; Betameth | 1983 |
Comparison of the antibacterial efficacy of 4% chlorhexidine gluconate and 1% triclosan handwash products in an acute clinical ward.
Topics: Anti-Infective Agents, Local; Bacterial Infections; Chlorhexidine; Colony Count, Microbial; Gram-Neg | 1999 |
Randomized trial of a hexachlorophene preparation and P-300 bacteriostatic soaps.
Topics: Bacterial Infections; Drug Combinations; Hexachlorophene; Humans; Phenyl Ethers; Salicylanilides; Sk | 1976 |
11 other studies available for triclosan and Bacterial Disease
| Article | Year |
|---|---|
Synthesis and antibacterial profiles of targeted triclosan derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteria; Bacterial Infections; Glucosides; Mic | 2019 |
Engineering surgical stitches to prevent bacterial infection.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Infections; Coated Materials, Biocomp | 2022 |
Resistance-driven innovations in the discovery of bactericides: novel triclosan derivatives decorating isopropanolamine moiety as promising anti-biofilm agents against destructive plant bacterial diseases.
Topics: Anti-Bacterial Agents; Bacterial Infections; Microbial Sensitivity Tests; Oryza; Oxadiazoles; Plant | 2023 |
An external ventricular drainage catheter impregnated with rifampicin, trimethoprim and triclosan, with extended activity against MDR Gram-negative bacteria: an in vitro and in vivo study.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Catheterization; | 2019 |
Percutaneous external fixator pins with bactericidal micron-thin sol-gel films for the prevention of pin tract infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Infections; Bone Nails; Coat | 2015 |
Efficacy of an ethanol/guar/triclosan/glycerine gel on bacteria and yeast loads in canine pododermatitis: a pilot study.
Topics: Animals; Anti-Infective Agents, Local; Bacterial Infections; Dog Diseases; Dogs; Ethanol; Female; Fo | 2016 |
Rapid antibacterial activity of 2 novel hand soaps: evaluation of the risk of development of bacterial resistance to the antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Infections; Benzethonium; Bi | 2008 |
Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery.
Topics: Anastomosis, Surgical; Animals; Anti-Infective Agents, Local; Antigens, CD; Bacterial Infections; Co | 2007 |
Antibacterial household products: cause for concern.
Topics: Anti-Infective Agents, Local; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Household | 2001 |
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.
Topics: Bacterial Infections; beta-Lactamases; Cephalosporins; Drug Design; Escherichia coli; Gram-Negative | 2002 |
[Clinical observations and statistical evaluation of the action of a new topical antimicrobial and antimycotic agent in pediatric skin diseases. Polycentric research].
Topics: Bacterial Infections; Child; Child, Preschool; Dermatomycoses; Drug Evaluation; Eczema; Female; Huma | 1978 |